A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 4

-Article 5

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6965416&loc=d3e5074-111524

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.4)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Name:	us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

Summary Of Significant Accounting Policies (Narrative) (Details) (USD $)				6 Months Ended
	Jun. 30, 2012	Jun. 29, 2012	Dec. 31, 2011	Jun. 30, 2012 The Lilly Agreement [Member]
Summary Of Significant Accounting Policies [Line Items]
Acquisition Price Per Share		$ 31.00
Aggregate purchase price		$ 5,300,000,000
Net Debt and Contractual Obligations to Lilly		1,700,000,000
Approximate Total Value of Acquisition		7,000,000,000
Percentage of operating profit shared				50.00%
Allowance for doubtful accounts	$ 200,000		$ 2,100,000